SUN PHARMACEUTICAL INDUSTRIES LTD Q4 RESULTS
Fairfax, Bain look to buy Gujarat API company Farmson
Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are in competition for a buyout of Farmson Basic Drugs, a leading API maker in India valued at ₹4,000 crore. Founded in 1969, Farmson is a major paracetamol manufacturer with a revenue of ₹1,750 crore in FY24. The company's concentrated focus on paracetamol production is a strength, but limited R&D poses challenges for diversification.
Buy Sun Pharmaceutical Industries, target price Rs 1895: JM Financial
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 426061.91 Crore) operating in Pharmaceuticals sector.
Q1 results shocker: 40 companies report more than 50% drop in profit
The profits of 40 Indian companies have plummeted by more than 50% in the June quarter, primarily due to higher raw material costs and unfavorable base effects. Notable names like Allcargo Logistics and Rajesh Exports saw drastic declines. Analysts suggest cautious investment strategies amid high market valuations and slowing profit growth.
Domestic pharmaceutical retail market grows 11 per cent in July
The domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain relief due to rising flu and viral infections. Antibiotic Augmentin led sales at Rs 72 crore and topped the charts. Overall market valued at Rs 2,22,906 crore, showing 7 per cent growth in June. Sun Pharma maintained a top position, with Indian companies growing at 11.4 per cent and MNCs at 10.2 per cent in July. Analysts predict a 10 per cent growth driven by demand for acute therapies like anti-infectives.
Hindalco Q1 Results: Cons PAT jumps 25% YoY to Rs 3,074 crore, revenue rises 8%
Hindalco Q1 Results: The Aditya Birla Group company's revenue from operations increased 7.6% to Rs 57,013 crore, and EBITDA surged 31% to Rs 7,992 crore. The India business achieved a 102% rise in consolidated PAT to Rs 1,957 crore.
Grasim Industries Q1 Results: Profit slides by a fourth to Rs 1,189 crore on investment in paints ops
The flagship company of the Aditya Birla launched its paints operations ‘Birla Opus’ towards the end of the March quarter, and April-June was its first quarter of full operations. The company has spent Rs 7,795 crore on its paints business as of June-end, approximately four-fifth of the total planned expenditure for these operations.
- Go To Page 1
Page Industries Q1 Results: Net profit rises 4.3% YoY to Rs 165.22 crore
The revenue increased by 3.9% from Rs. 1,229.07 crores to Rs. 1,277.52 crores in the period under review. The sales volume grew by 2.6% year-on-year to 5.74 crore pieces
Grasim Industries Q1 preview: Revenue uptick seen at 17-25% YoY, PAT may fall on losses in VSF, paints biz
Grasim Industries' net profit for Q1 ending June 30, 2024, is projected to be between Rs 104 crore and Rs 231 crore, with revenue expected to see a 17%-25% YoY increase. However, losses in the VSF and paints segments are likely to pull down the PAT figures, compounded by weak operating margins.
Q1 results today: LIC, RVNL, GRSE, MRF among 225 companies to announce earnings on Thursday
The initial quarter earnings season began with 225 companies, including LIC, Eicher Motors, RVNL, and SAIL, reporting their financial performance. Eicher Motors was expected to achieve a significant profit range, while LIC was projected to see a notable increase in its annual premium equivalent and value of new business on a yearly basis.
Bharti Airtel Q1 Results: Cons PAT soars 158% YoY to Rs 4,160 crore, ARPU at Rs 211
Bharti Airtel Q1 Results: While an ET Now poll estimated a profit of around Rs 3,661 crore, the actual profit for the reporting period surpassed this, with revenue from operations growing 3% year-on-year to Rs 38,506 crore. This figure is marginally below the poll's revenue estimates of Rs 38,523 crore. In the first quarter of the previous fiscal year, the company reported a profit of Rs 1,612 crore and revenue of Rs 37,440 crore.
Eveready Industries Q1 Results: Net profit rises 18% YoY to 29.3 crore, revenue dips 4%
Eveready Industries India saw an 18.1% increase in Q1 net profit, reaching Rs 29.36 crore, while revenue declined by 3.9% to Rs 349.37 crore. The company attributed the revenue dip to multiple factors, including a high base effect and a slowdown in some products, but highlighted gains from premiumisation and innovation.
ITC Q1 Results: Standalone PAT rises marginally to Rs 4,917 crore, misses estimates
ITC reported a slight increase in its standalone net profit for the quarter ending June 30, 2024, reaching Rs 4,917.45 crore, up from Rs 4,902.74 crore a year earlier. However, this figure was below analysts' expectations of Rs 5,122 crore.
Sun Pharma Q1 Results: Net profit rises 40% YoY to Rs 2,836 crore, beats estimates
Sun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 crore. Revenue rose 6% YoY to Rs 12,653 crore. EBITDA grew 8% YoY to Rs 3,608 crore with margins at 28.5%. India formulation sales reached Rs 4,144 crore, up 16%, constituting 33.1% of total sales.
Maruti Suzuki shares climb 4% to hit 52-week high on strong Q1 performance. Should you buy, sell or hold?
Maruti Suzuki Shares Price: Maruti Suzuki’s shares surged 4% to a 52-week high of Rs 13,675 on Thursday, following strong Q1 FY24 earnings. The company reported a 46.9% YoY increase in standalone profit to Rs 3,650 crore, exceeding estimates. However, Q1 revenue rose 9.82% YoY to Rs 33,875 crore, missing the estimate.
M&M expected to outperform industry growth this year, especially in PV segment: Abhishek Gaoshinde
M&M's tractor segment exhibited solid performance while the automotive segment remained steady, leading to higher-than-expected EBITDA margins. Despite lower other income affecting the bottom line, the operational results were good. Projections indicate that new capacities and a strong order book will drive valuation improvements with potential EV business value unlocking.
Q1 results this week: ITC, SBI, TaMo, Zomato among 130 firms to announce earnings
This week, several prominent companies released their June quarter financial results. Firms like ITC, SBI, Adani Ports, Tata Motors, and M&M showcased their reports between July 29th and August 3rd. The updates offered a glimpse into their quarterly performance, engaging the attention of investors and stakeholders.
Q1 results today: ICICI Bank, Dr Reddy's among 34 companies to announce earnings on Saturday
Finolex Industries, IEC Education, IFB Industries, J&K Bank, Jaiprakash Power, SBFC Finance, Vishal Fabrics, Spandana Sphoorty, Smruthi Organics, NTPC, Genus Power, Gujarat Cotex among others will also declare their June quarter results.
RIL Q1 Results: PAT drops 5% YoY to Rs 15,138 crore; revenue jumps 12%
RIL Q1 Results: Mukesh Ambani-led Reliance reported a 5% decrease in its consolidated net profit for the quarter ending June 2024, amounting to Rs 15,138 crore compared to Rs 16,011 crore in the same period last year. Despite this, revenue from operations grew by 12% YoY to Rs 2.36 lakh crore. The reported profit fell significantly short of Street expectations of around Rs 16,341 crore.
Reliance Jio Q1 Results: PAT jumps 12% YoY to Rs 5,445 crore, revenue rises 10%
Reliance Jio Q1 Results: The Reliance Industries' telecom subsidiary reported revenue from operations at Rs 26,478 crore, an increase of 10% from Rs 24,042 crore reported in the corresponding period of the previous financial year. The standalone revenue was up 2% on a quarter-on-quarter basis from Rs 25,959 crore reported in the January-March quarter.
DOMS shares rally 10% to fresh all-time high after Q4 results; brokerages increase target up to Rs 2,121
DOMS Industries witnessed a remarkable surge of 10% in its shares on Tuesday on the BSE, reaching a new all-time high of Rs 2,035. This surge followed the company's announcement of a 29.6% year-on-year (YoY) increase in its Q4 profit after tax (PAT), which amounted to Rs 46.93 crore.
Q4 results today: LIC, NMDC among 236 companies to announce earnings on Monday
236 companies, including LIC and NMDC, to announce Q4 results. LIC reported a 49% rise in Q3 earnings, while NMDC saw a 62% increase in consolidated net profit.
Sun Pharma shares tumble 5% but brokerages raise target up to Rs 1,785. Should you buy, sell or hold?
In Thursday's trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day's low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.
Balkrishna Industries shares jump 5% post Q4 results
Balkrishna Industries Share Price: Shares of BKT surged 5% on Saturday to its fresh 52-week high of Rs 2,798.95 supported by the company’s solid fourth quarter performance. Its net profit soared 88% while revenue jumped 16% to Rs 2,697 crore on the back of a sales volume of 82,085 MT.
Load More
